McKesson Profit Margin 2006-2019 | MCK

Current and historical gross margin, operating margin and net profit margin for McKesson (MCK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. McKesson net profit margin as of March 31, 2019 is 0.02%.
McKesson Annual Profit Margins
McKesson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.522B $214.319B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.117B 21.02
Align Technology (ALGN) United States $24.630B 66.49
AmerisourceBergen (ABC) United States $16.907B 12.01
Laboratory Of America Holdings (LH) United States $16.375B 15.31
Cooper (COO) United States $14.414B 25.15
Cardinal Health (CAH) United States $13.684B 8.86
DENTSPLY SIRONA (XRAY) United States $12.574B 26.22
Henry Schein (HSIC) United States $10.088B 16.96
West Pharmaceutical Services (WST) United States $8.529B 39.61
Merit Medical Systems (MMSI) United States $2.870B 29.81
CONMED (CNMD) United States $2.286B 36.48
Patterson (PDCO) United States $2.079B 16.43
Atrion (ATRI) United States $1.655B 47.25
STAAR Surgical (STAA) United States $1.068B 72.79
Antares Pharma (ATRS) United States $0.462B 0.00
Invacare (IVC) United States $0.216B 0.00
Lifevantage (LFVN) United States $0.159B 20.98
Endologix (ELGX) United States $0.111B 0.00
Pro-Dex (PDEX) United States $0.056B 17.35
Biolase (BIOL) United States $0.042B 0.00
Retractable Technologies (RVP) United States $0.021B 0.00
Milestone Scientific (MLSS) United States $0.013B 0.00